-
Congress' biotech panel pitches FDA policy upgrades to help performance
13 Jan 2026 05:15 GMT
-
Inside Biotech: Eikon Therapeutics joins IPO queue with late-stage...
13 Jan 2026 05:41 GMT
… 2026 biotech markets
Science-driven, clinical-focused — and led by industry … oncology — attractive themes for biotech investors chasing differentiated science and … underscores the uncertainties inherent in biotech investing — including clinical outcomes, …
-
New year, new leadership: Biotech firms shake up 2026 with executive appointments
13 Jan 2026 02:57 GMT
… has over 30 years of industry experience, with 23 of those … for nine years.
And finally, biotech supplier NanoTemper Technologies announced the …
-
JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
13 Jan 2026 00:43 GMT
… , neither was the biotechnology industry.
A historic market downturn … John Maraganore, the multihyphenate biotech expert who served as founding … Brad Loncar, a prominent biotech investor turned media analyst, … ’ for U.S. biotech
Takeda Pharmaceutical was on the …
-
MKS Inc. Unveils Photonics Solutions to Advance AI, Quantum, and Biotech at Photonics West 2026
12 Jan 2026 21:30 GMT
… of breakthroughs in AI, quantum, biotech, and beyond.” Visitors to … accuracy for quantum research and industrialization. Showcase Highlights:
Spectra-Physics … for precise experimental control.
Biotech Innovation
Biophotonics is transforming healthcare …
-
Incubate Investor Survey: U.S. Policy Will Decide U.S.-China Race for Biotech Leadership
12 Jan 2026 15:30 GMT
… to completely leave the biotech sector." Investors … impact investment in the biotech sector. Respondents identified the … number one influence for biotech investors. However, policies … with Incubate's industry-leading Life Sciences Investment …
-
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer
12 Jan 2026 14:00 GMT
Compared to the historical benchmark, pelareorep-atezolizumab nearly tripled ORR Combination achieved encouraging median DOR of almost 17 months Data establishes clear path in indication with no approved therapy SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) …
-
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
12 Jan 2026 13:00 GMT
… NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader … Executive Officer of Legend Biotech. “Legend Biotech is poised for transformative growth … U.S. litigation process; government, industry, and general product pricing and …
-
JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree
12 Jan 2026 13:21 GMT
… Medicines, a US-based biotech developing cancer drugs. Revolution’ … since Pfizer bought cancer biotech Seagen for $43bn in … pharma companies are circling the biotech.
In another emailed statement … on the latest healthcare industry trends emerging from the …
-
Pre-summit on AI impact in biotech and medtech held ahead of India–AI Impact Summit 2026
12 Jan 2026 10:56 GMT
A pre-summit event titled “AI Impact in biotech and medtech innovation – The Next Frontier” was held at the FITT, IIT Delhi Auditorium ahead of the India–AI Impact Summit 2026. The event brought together AI-driven biotech and medtech startups, investors, …
About
© 1995-2026